Ground News

institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

neurologylive.com image

News from neurologylive.com

See all of neurologylive.com’s headline news. Compare how the top news stories are covered by left-wing and right-wing news sources.

We’ve discovered 384 headlines written by neurologylive.com during the past 3 months.

Ground News rates neurologylive.com’s media bias as unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

neurologylive.com’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about neurologylive.com

Where is neurologylive.com located?neurologylive.com's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top neurologylive.com News

FDA Expands Indications for Neuraceq®, an Amyloid PET Imaging Agent, to Enhance Diagnosis and Care of Patients with Alzheimer's Disease

FDA · Charleston

FDA Expands Indications for Neuraceq®, an Amyloid PET Imaging Agent, to Enhance Diagnosis and Care of Patients with Alzheimer's Disease

67% Center coverage: 21 sources

New indication added for selection of patients for amyloid-directed therapies See the Story

FDA Says It's Investigating Sarepta’s Duchenne Patient Deaths

United States · United States

FDA Says It's Investigating Sarepta’s Duchenne Patient Deaths

83% Center coverage: 12 sources

(MedPage Today) -- The FDA is investigating the deaths of two boys with Duchenne muscular dystrophy who died soon after being treated with delandistrogene moxeparvovec (Elevidys) gene therapy, the agency said. The investigation will focus on the...See the Story

Targeting a Key Enzyme Could Reverse Early Parkinson's Effects

Parkinson's Disease · Stanford

Targeting a Key Enzyme Could Reverse Early Parkinson's Effects

100% Center coverage: 3 sources

Putting the brakes on an enzyme might rescue neurons that are dying due to a type of Parkinson's disease that's caused by a single genetic mutation, according to a new Stanford Medicine-led study conducted in mice.See the Story

Parkinson’s Disease Tremor Explained by Reflex Loop Changes

100% Center coverage: 1 sources

Many Parkinson’s Disease tremor behaviors that were considered hard to interpret can be explained by control systems modeling of mid-level motor control. The model in this paper includes stretch reflex loop with feedback delay and tonically controlled antagonist muscles. It also includes Basal Ganglia circuit that commands (schedules) gain changes in the reflex feedback loop. Computational analysis of the control systems model shows how the gain…Parkinson's Disease See the Story

DORA Class for Treating Insomnia

A panelist discusses how dual orexin receptor antagonists (DORAs) offer a novel approach to treating insomnia by reducing wakefulness rather than inducing sedation, highlighting the importance of patient education on their gradual onset, distinct mechanism, and the need for consistent use to achieve long-term benefits.See the Story

Revisiting Deep Brain Stimulation in a Pediatric-Onset Dystonia Case: Pamela Zeilman, NP

The nurse practitioner in the Center for Movement Disorders & Neurorestoration at the University of Florida discussed a complex case of childhood-onset dystonia treated with DBS. [WATCH TIME: 6 minutes]Gainesville, Florida · Gainesville Read Article

Overviewing Pivotal Phase 3 TEMPLE Trial of Atogepant vs Topiramate: Jessica Ailani, MD

The director of the MedStar Georgetown Headache Center discussed results from the phase 3 TEMPLE trial, which showed improved tolerability and cognitive outcomes with atogepant vs topiramate in episodic migraine. [WATCH TIME: 5 minutes]Maryland · Maryland Read Article

Switch From Amantadine Immediate-Release to Gocovri Results in Improved Real-World Parkinson Disease Benefits

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.Read Article

Validating a Wearable-Based Classifier to Detect iRBD: Emmanuel During, MD

The associate professor of neurology at the Icahn School of Medicine at Mount Sinai explained how his team validated an iRBD actigraphy classifier across new devices and datasets to enhance early, scalable screening for neurodegenerative disease. [WATCH TIME: 5 minutes]Maryland · Maryland Read Article

FDA News Recap: June 2025

This FDA News Month in Review provides a round-up of regulatory decisions from June 2025.United States · United States See the Story

Expert Perspectives on The Importance of Multidisciplinary Care for Patients With Duchenne Muscular Dystrophy

A panelist discusses how DMD progression affects different muscle groups over time, with the most serious complications involving respiratory and cardiac muscles, necessitating specialized care from pulmonologists and cardiologists.Read Article

Breaking News Topics Related to neurologylive.com